Treatment of youth depression in primary care under usual practice conditions: Observational findings from youth partners in care

Journal of Child and Adolescent Psychopharmacology

Volumn 22, Issue 1, 2012, Pages 80-90

  Wells, Kenneth B ^a   Tang, Lingqi ^a   Carlson, Gabrielle A ^b   Asarnow, Joan Rosenbaum ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGIC STUDY DEPRESSION SCORE; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PSYCHOMETRY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; YOUTH DEPRESSION;

ADOLESCENT; ALGORITHMS; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857298128     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2011.0074     Document Type: Article

References (43)

1. Angrist JD, Imbens GW, Rubin DB: Identification of causal effects using instrumental variables. J Am Stat Assoc 91:444-455, 1996. (Pubitemid 126412813)
2. Asarnow JR, Carlson G, Schuster M, Miranda J, Jackson-Triche M, Wells KB: Youths Partners in Care: Clinician Guide to Depression Assessment and Management Among Youth in Primary Care Settings. Los Angeles, CA: UCLA School of Medicine; 1999.
3. Adapted from: Rubenstein L, Unutzer J, Miranda J, et al. Partners in Care: Clinician Guide to Depression Assessment and Man-agement in Primary Care Settings. Santa Monica, CA: RAND; 1996.
4. Asarnow JR, Jaycox LH, Clarke G, Lewinsohn P, Hops H, Rohde P: Stress and Your Mood: A Manual. Los Angeles, CA: UCLA School of Medicine; 1999.
5. Asarnow JR, Jaycox LH, Duan N, La Borde AP, Rea MM, Murray P, Anderson M, Landon C, Tang L, Wells KB: Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: A randomized controlled trial. JAMA 293:311-319, 2005. (Pubitemid 40116086)
6. Asarnow JR, Jaycox LH, Tang L, Duan N, La Borde AP, Zeledon LR, Anderson M, Murray P, Landon C, Rea M, Wells KB: Are there long-term benefits of short-term quality improvement interventions for depressed youth in primary care? Am J Psychiatry 166:1002-1010, 2009.
7. Barry CL, Huskamp HA: Moving beyond Parity\-Mental health and addiction care under the ACA. N Engl J Med, 2011. Available at www.nejm.org/doi/full/10. 1056/NEJMp1108649?ssource = hcrc
8. Berwick DM, Murphy JM, Goldman PA, Ware JE Jr., Barsky AI, Weinsten MC: Performance of a five-item mental health screening tests. Med Care 29:169-176, 1991.
9. Bhattacharya J, Goldman D, Mc Caffrey D: Estimating probit models with self-selected treatments. Stat Med 25:389-413, 2006. (Pubitemid 43174538)
10. Birmaher B, Brent D, AACAP Work Group on Quality Issues, Bernet A, Burkstein O, Walter H, Benson RS, Christman A, Farchione T, Greenhill L, Hamilton J, Keable H, Kinlan J, Schoettle U, Stock S, Ptakowsi KK, Medicus J: Practice parameter for the assessment and treatment of children and adolescents with de-pressive disorders. J Am Acad Child Adolesc Psychiatry 46:1503-1526, 2007.
11. Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, Vitiello B, Ritz L, Iyengar S, Abebe K, Birmaher B, Ryan N, Kennard B, Hughes C, De Bar L, Mc Cracken J, Strober M, Suddath R, Spirito A, Leonard H, Melhem N, Porta G, Onorato M, Zelazny J: Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. JAMA 299:1683-1696, 2009.
12. Campo JV, Bridge JA: Treatment of youth depression. Am J Psychiatry 166:958-960, 2009.
13. Clarke GN, Hawkins W, Murphy M, Sheeber LB, Lewinsohn PM, Seeley JR: Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents. J Am Acad Child Adolesc Psychiatry 34:312-321, 1995.
14. Clarke GN, Lewinsohn PM, Hops H, Seeley JR: Adolescent Coping with Depression Course. Eugene, OR: Castalla Press; 1990.
15. Clarke GN, Rohde P, Lewinsohn PM, Hops H, Seeley J: Cognitive-behavioral treatment of adolescent depression. J Am Acad Child Adolesc Psychiatry 38:272-279, 1999.
16. Eaton DK, Kann L, Kinchen S, Shanklin S, Ross J, Hawkins J, Harris WA, Lowry R, Mc Manus T, Chyen D, Lim C, Whittle L, Brener ND, Wechsler H, Centers for Disease Control and Prevention (CDC): Youth risk behavior surveillance\-United States, 2009. MMWR Surveill Summ 59:1-142, 2009.
17. Emslie G, Rush JA, Weinbger WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J: A double-blind, randomized placebo-controlled trial of fluoxetine in depressed children and adolescents. Arch Gen Psychiatry 54:1031-1037, 1997. (Pubitemid 27476099)
18. Garber J, Clarke GN, Weersing VR, Beardslee WR, Brent DA, Gladstone TR, De Bar LL, Lynch FL, D'Angelo E, Hollon SD, Shamseddeen W, Iyengar S: Prevention of depression in at-risk adolescents: A randomized controlled trial. JAMA 301:2215-2224, 2009.
19. Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Har-rington R: A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial. Health Technol Assess 12:iii-iv, ix-60, 2008.
20. Heckman J: Randomization as an instrumental variable: Notes. RE Stat 78:336-341, 1996.
21. Horwitz SM, Hoagwood K, Stiffman AR, Summerfeld T, Weisz JR, Costello EJ, Rost K, Bean DL, Cottler L, Leaf PJ, Roper M, Nor-quist G: Measuring youths' use of mental health services: Relia-bility of the Services Assessment for Children and Adolescents (SACA). Psychiatry Serv 52:1088-1094, 2001.
22. Horwitz SM, Leaf PJ, Leventahl JM, Forsthy B, Speechely KN: Identification and management of psychosocial and developmental problems in community-based, primary care pediatric practices. Pediatrics 89:480-485, 1992.
23. Hughes CW, Emslie GJ, Crismon MO, Wagner KD, Birmaher B, Geller B, Pliszka SR, Ryan ND, Strober M, Trivedi MH, Toprac MG, Sedillo A, Llana ME, Lopez M, Rush AJ: The Texas Chil-dren's Medication Algorithm Project: Report of the Texas Con-sensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry 38:1442-1454, 1999. (Pubitemid 29513403)
24. Imbens GW, Rosenbaum PR: Randomization inference with an in-strumental variable. J R Stat Soc Series A 168:109-126, 2005.
25. Imbens GW, Rubin DB: Bayesian inference for causal effects in randomized experiments with noncompliance. Ann Stat 25:305-327, 1997.
26. Jensen PS, Bhatara VS, Vitiello B, Hoagwood K, Feil M, Burke LB: Psychoactive medication prescribing practices for U.S. children. J Am Acad Child Adolesc Psychiatry 38:557-565, 1999.
27. Kessler RC: Epidemiology of depression. In: Handbook of Depres-sion, edited by I. Gotlib, CL. Hammen. New York: Guildford Press; 2002; pp. 23-42.
28. Korn EL, Graubard BI: Predictive margins with survey data. Bio-metrics 55:652-659, 1999. (Pubitemid 29302598)
29. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, Mc Nulty S, Vitiello B, Severe J: Treatment for Ado-lescents with Depression Study (TADS) Group. Fluoxetine, cog-nitive-behavioral therapy, and their combination for adolescents with depression. JAMA 292:807-820, 2004.
30. Mc Lellan M, Mc Neil BJ, Newhouse JP: Does more intensive treat-ment of acute myocardial infarction in the elderly reduce mortality? JAMA 272:859-866, 1994. (Pubitemid 24282095)
31. Miranda J, Schoenbaum M, Sherbourne C, Duan N, Wells K: Effects of Primary care depression treatment on minority patients' clinical status and employment. Arch Gen Psych 61:827-834, 2004. (Pubitemid 39031122)
32. Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM: A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 62:577-584, 2004. (Pubitemid 38747312)
33. Radloff LS: The CES-D Scale: A self report depression scale for research in the general population. Appl Psychol Meas 1:385-401, 1977.
34. Rosenbaum PR: Design of Observational Studies. New York: Springer; 2010.
35. Schoenbaum M, Unutzer J, Mc Caffrey D, Duan N, Sherbourne C, Wells KB: The effects of primary care depression treatment on patients' clinical status and employment. Health Services Res 37:1145-1158, 2002. (Pubitemid 35398453)
36. Sturm R: Instrumental variable methods for effectiveness research. Int J Methods Psychiatr Res 7:17-26, 2006.
37. Sturm R, Wells KB: How can care for depression become more costeffective? JAMA 273:51-58, 1995.
38. U.S. Food and Drug Administration: Public Health Advisory: Suicidality in Children and Adolescents Being Treated with Antidepressant Medications, October 15, 2004. Available at www.fda.gov/cder/drug/antidepressants/default.htm
39. Vitiello B, Swedo S: Antidepressant medications in children. N Engl J Med 350:1489-1491, 2004. (Pubitemid 38477772)
40. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, Childress A, Donnelly C, Deas D: Sertraline Pediatric Depression Study Group: Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. JAMA 290:1033-1041, 2004a.
41. Wagner KD, Robb AS, Finding RL, Jin J, Gutierrez MM, Heydorn WE: A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 161:1079-1083, 2004b. (Pubitemid 38735994)
42. Weisz JR, Doss AJ, Hawley KM: Youth psychotherapy outcome research: A review and critique of the evidence base. Ann Rev Psych 56:337-363, 2005. (Pubitemid 40300789)
43. Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unützer J, Miranda J, Carney MF, Rubenstein LV: Impact of disseminating quality improvement programs for depression in managed primary care: A randomized controlled trial. JAMA 283: 212-220, 2000. (Pubitemid 30039221)